Hims & Hers Health (HIMS) Research & Development (2021 - 2026)
Hims & Hers Health (HIMS) posted Research & Development of $46.9 million for Q1 2026, up 14.58% sequentially from $41.0 million in Q4 2025, and up 56.9% YoY from $29.9 million in Q1 2025.
Hims & Hers Health (HIMS) Research & Development (2021 - 2026) Analysis & Trends
Hims & Hers Health has reported Research & Development for 6 years, with the latest figure at $46.9 million in Q1 2026.
- Quarterly Research & Development rose 56.9% year-over-year to $46.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $166.3 million (up 78.06% YoY) and the FY2025 annual result came in at $149.3 million, up 89.42% from the prior year.
- Research & Development rose to $46.9 million in Q1 2026 per HIMS's latest filing, from $41.0 million in the prior quarter.
- Over five years, Research & Development peaked at $46.9 million in Q1 2026 and troughed at $6.1 million in Q1 2022.
- A 5-year average of $20.7 million and a median of $15.3 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development rose 27.8% in 2022, then surged 102.89% in 2025.
- Over 5 years, Research & Development stood at $8.3 million in 2022, then soared by 61.29% to $13.4 million in 2023, then jumped by 77.17% to $23.7 million in 2024, then jumped by 72.48% to $41.0 million in 2025, then grew by 14.58% to $46.9 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $46.9 million, $41.0 million, and $40.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Hims & Hers Health | 7.51 Bn | 6.67 Bn | 480.80 Mn | 54.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.90 Mn |
| Mar 31, 2026 | 46.94 Mn |
| Dec 31, 2025 | 40.96 Mn |
| Sep 30, 2025 | 40.58 Mn |
| Jun 30, 2025 | 37.85 Mn |
| Mar 31, 2025 | 29.91 Mn |
| Dec 31, 2024 | 23.75 Mn |
| Sep 30, 2024 | 21.09 Mn |
| Jun 30, 2024 | 18.65 Mn |
| Mar 31, 2024 | 15.32 Mn |
| Dec 31, 2023 | 13.41 Mn |
| Sep 30, 2023 | 12.27 Mn |
| Jun 30, 2023 | 11.80 Mn |
| Mar 31, 2023 | 10.75 Mn |
| Dec 31, 2022 | 8.31 Mn |
| Sep 30, 2022 | 7.98 Mn |
| Jun 30, 2022 | 6.86 Mn |
| Mar 31, 2022 | 6.09 Mn |
| Dec 31, 2021 | 5.57 Mn |
| Sep 30, 2021 | 6.24 Mn |